PTC is pitching a conversion to a SaaS model story and hyping its IoT business with misleading growth and market share figures; we find significant holes in both stories. PTC shares are +100% in the ...

PTC Therapeutics has demonstrated resilience in its financial performance, with the company recently raising its 2024 revenue guidance to $750 million-$800 million, up from the previous range of $700 ...

PTC Inc., a key player in the U.S. software industry specializing in industrial connectivity and Internet of Things (IoT) solutions, stands at a pivotal moment in its corporate journey. The company’s ...

Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is PTC Therapeutics Inc (NASDAQ:PTCT). The stock, which is ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines ...

ARR Growth: 10% year-over-year, reaching $2.326 billion on a constant currency basis. Free Cash Flow Growth: 13% year-over-year, with $279 million generated in Q2. Leverage Ratio: Reduced to 1.5 times ...

PTC’s aftermarket stock price increased by 0.59% to $198.43 following the earnings release, indicating positive investor sentiment despite the stock trading below its 52-week high of $219.69. Detailed ...

WILSONVILLE, Ore.--(BUSINESS WIRE)--Mentor Graphics Corporation (NASDAQ: MENT) today announced the availability of its FloEFD™ v11.3 Concurrent Computational Fluid Dynamics (CFD) technology, the ...

PTC Inc. recently launched the Arena PLM and QMS AI Engine, a cutting-edge solution designed to bring AI-powered intelligence directly into core product lifecycle and quality work ...